Cempra Inc is a clinical-stage pharmaceutical company which is developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases particularly respiratory tract infections and skin and skin structure infections.


Updates from The Motley Fool

Latest updates on Cempra from Fool.com.
Why Cempra Inc Got Crushed Today

Image source: Getty Images. What happened Cempra (NASDAQ: CEMP) ended the day down 21% after ann...

Why Cempra Inc is Up Big Today

What: Shares of  Cempra (NASDAQ: CEMP), a clinical-stage biopharma focused on developing next-g...

Is Cempra's 33% Drop Warranted?

What : Shares of Cempra (NASDAQ: CEMP), a clinical-stage biopharma, crashed today following a p...

IPOs Are Back

There's new blood in the IPO pipeline. After a sleepy January that saw just three new issues hit ...



Stock Performance

View Interactive CEMP Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cempra.
Current Price: $7.55
Prev Close: $6.55
Open: $6.55
Bid: $7.55
Ask: $7.70
Day's Range: $6.45 - $7.60
52wk Range: $5.70 - $32.96
Volume: 1,675,995
Avg Vol 3,064,108
Market Cap: $332M
P/E (ttm): -2.95
EPS (ttm): ($2.22)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cempra.
CAPS Rating 4 out of 5
 
76 Outperform
5 Underperform
CAPS All Stars
 
19 Outperform
2 Underperform

How do you think Cempra will perform against the market?



You pick for Cempra is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Cempra.

Cempra Inc is a clinical-stage pharmaceutical company which is developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases particularly respiratory tract infections and skin and skin structure infections.

  • Exchange: NASDAQ